BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2656443)

  • 1. [Immunopathologic and inflammatory processes in chronic polyarthritis. Discussion principles of the mechanisms of action of antirheumatic drugs].
    Mathies H
    Fortschr Med; 1989 Mar; 107(9):197-200. PubMed ID: 2656443
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of neutrophils in the pathogenesis of rheumatoid arthritis and their changes as affected by anti-rheumatic agents].
    Malinovskaia EI
    Revmatologiia (Mosk); 1988; (2):63-8. PubMed ID: 3051279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of interleukin 1 and related monokines in the pathogenesis of chronic polyarthritis].
    Hermann E; Müller W
    Z Rheumatol; 1985; 44(5):207-12. PubMed ID: 3878640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunology of primary chronic polyarthritis].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 May; 94(22):1196-200. PubMed ID: 4889779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recently discovered mechanisms of action of non-steroidal antirheumatic agents: possible, not only symptomatic therapeutic effects].
    Juan H
    Wien Klin Wochenschr; 1983 Dec; 95(24):865-9. PubMed ID: 6608183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-immunological analysis of the use of nonsteroid anti-inflammatory agents in rheumatoid arthritis].
    Beneson EV; Alibekova RI; Nemtsov BF; Ualieva TM
    Revmatologiia (Mosk); 1984; (1):38-40. PubMed ID: 6372003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of the phagocytic ability of leukocytes in patients with chronic polyarthritis].
    Teherani DK; Bröll H; Altmann H; Tausch G; Eberl R; Wallisch G
    Z Rheumatol; 1984; 43(1):15-7. PubMed ID: 6711144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levamisole and rheumatoid arthritis].
    Cats A
    Ned Tijdschr Geneeskd; 1980 Apr; 124(14):508-11. PubMed ID: 6966379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic polyarthritis with non-steroidal antirheumatic agents with symptomatic effect; quo vadis?].
    Bach GL
    Ther Ggw; 1978 Nov; 117(11):1782-94. PubMed ID: 725805
    [No Abstract]   [Full Text] [Related]  

  • 12. Infection in patients with rheumatoid arthritis with special reference to rheumatoid surgery.
    von Essen R; Leirisalo-Repo M; Hämäläinen MM
    Ann Chir Gynaecol Suppl; 1985; 198():110-6. PubMed ID: 3901872
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow acting antirheumatic drugs in rheumatoid arthritis.
    Gow PJ
    N Z Med J; 1993 Mar; 106(951):85-7. PubMed ID: 8474708
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis.
    Gerli R; Pitzalis C; Lunardi C
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):949-52. PubMed ID: 12455188
    [No Abstract]   [Full Text] [Related]  

  • 15. What is a disease modifying antirheumatic drug?
    Hepburn B
    J Rheumatol Suppl; 1988 Sep; 16():40-2. PubMed ID: 2903926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in inflammation applicable to chronic evolutive polyarthritis].
    Willoughby DA; Giroud JP; Velo GP
    Brux Med; 1974 Mar; 54(3):135-8. PubMed ID: 4362561
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary immune reactions in patients with chronic polyarthritis under cytostatic ("immunosuppressive") therapy].
    Krull P; Fricke R; Wittenborg A; Deicher H
    Z Rheumaforsch; 1972; 31(5):202-9. PubMed ID: 5065469
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
    Phadke K; Carroll J; Nanda S
    Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles and mechanism of action of drug therapy of rheumatoid arthritis].
    Abrahamsen TG
    Tidsskr Nor Laegeforen; 1980 Aug; 100(23):1346-9. PubMed ID: 7456011
    [No Abstract]   [Full Text] [Related]  

  • 20. Slow-acting antirheumatic drugs.
    Drug Ther Bull; 1993 Mar; 31(5):17-20. PubMed ID: 8348881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.